A Study of Xeloda (Capecitabine) Compared With 5-Fluorouracil in Combination With Low-Dose Leucovorin in Patients Who Have Undergone Surgery for Colon Cancer

NCT00009737 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

1987

Enrollment

INDUSTRY

Sponsor class

Conditions

Colorectal Cancer

Interventions

DRUG: 5-Fluorouracil
DRUG: Leucovorin
DRUG: Capecitabine [Xeloda]

Sponsor

Hoffmann-La Roche